Enanta Pharmaceuticals Inc operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Enanta Pharmaceuticals Inc with three other
companies in this sector in the United States:
Integrated Biopharma, Inc.
sales of $46.95 million
Array BioPharma Inc.
of which 100%
was Small Molecular Drugs), and
China Yct International Group, Inc.
During the year ended September of 2017, sales at
Enanta Pharmaceuticals Inc were $102.81 million.
increase of 16.5%
versus 2016, when the company's sales were $88.27 million.
Despite this increase, sales are still
below the level achieved in 2015, when Enanta Pharmaceuticals Inc
reported sales of $160.88 million.